BCL-Xl Down-Regulation Suppresses the Tumorigenic Potential of NPM/ALK in Vitro and in Vivo

Blood - United States
doi 10.1182/blood-2003-09-3144
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Neutralization of BCL-2/XL Enhances the Cytotoxicity of T-Dm1 in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

BCL-xL in Neuroprotection and Plasticity

Frontiers in Physiology
Physiology
2014English

Structure-Based Design of Potent BCL-2/BCL-xL Inhibitors With Strong in Vivo Antitumor Activity

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2012English

Synthesis and Evaluation of Apogossypol Atropisomers as Potential BCL-xL Antagonists

Cancer Letters
Cancer ResearchOncology
2009English

Emodin Suppresses Proliferation, Migration and Invasion in Ovarian Cancer Cells by Down Regulating ILK in Vitro and in Vivo

OncoTargets and Therapy
OncologyPharmacology
2017English

Bax and BCL-xL Exert Their Regulation on Different Sites of the Ceramide Channel

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2012English

RNA Interference by Expression of Short Hairpin RNAs Suppresses BCL-xL Gene Expression in Nasopharyngeal Carcinoma Cells1

Acta Pharmacologica Sinica
MedicinePharmacology
2005English

Serum Starvation-Induces Down-Regulation of BCL-2/Bax Confers Apoptosis in Tongue Coating-Related Cells In�vitro

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

CHIP Suppresses Polyglutamine Aggregation and Toxicity in Vitro and in Vivo

Journal of Neuroscience
Neuroscience
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy